MRTX
Marshall Wace’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-147,144
| Closed | -$6.41M | – | 2494 |
|
|
2023
Q3 | $6.41M | Sell |
147,144
-437,179
| -75% | -$19M | 0.01% | 714 |
|
|
2023
Q2 | $21.1M | Buy |
584,323
+31,709
| +6% | +$1.15M | 0.04% | 409 |
|
|
2023
Q1 | $20.5M | Buy |
+552,614
| New | +$20.5M | 0.04% | 400 |
|
|
2022
Q1 | – | Sell |
-83,364
| Closed | -$12.2M | – | 3663 |
|
|
2021
Q4 | $12.2M | Buy |
83,364
+43,132
| +107% | +$6.33M | 0.02% | 670 |
|
|
2021
Q3 | $7.12M | Sell |
40,232
-4,470
| -10% | -$791K | 0.03% | 671 |
|
|
2021
Q2 | $7.22M | Sell |
44,702
-2,842
| -6% | -$459K | 0.03% | 572 |
|
|
2021
Q1 | $8.14M | Sell |
47,544
-323,062
| -87% | -$55.3M | 0.04% | 511 |
|
|
2020
Q4 | $81.4M | Sell |
370,606
-57,793
| -13% | -$12.7M | 0.44% | 30 |
|
|
2020
Q3 | $71.1M | Buy |
+428,399
| New | +$71.1M | 0.46% | 35 |
|
|
2020
Q1 | – | Sell |
-7,482
| Closed | -$964K | – | 2107 |
|
|
2019
Q4 | $964K | Buy |
+7,482
| New | +$964K | 0.01% | 952 |
|
|
2019
Q2 | – | Sell |
-4,853
| Closed | -$356K | – | 1918 |
|
|
2019
Q1 | $356K | Buy |
4,853
+4,653
| +2,327% | +$341K | ﹤0.01% | 1219 |
|
|
2018
Q4 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 1535 |
|
|
2018
Q2 | – | Sell |
-8,740
| Closed | -$268K | – | 875 |
|
|
2018
Q1 | $268K | Buy |
+8,740
| New | +$268K | 0.01% | 483 |
|